Antioxidant properties of calcium antagonists related to membrane biophysical interactions
- 16 August 1999
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 84 (4) , 16-22
- https://doi.org/10.1016/s0002-9149(99)00360-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Membrane Antioxidant Effects of the Charged Dihydropyridine Calcium Antagonist AmlodipineJournal of Molecular and Cellular Cardiology, 1999
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Antioxidant properties of active and inactive isomers of nicardipine in cardiac membranes, endothelial cells, and perfused rat heartsCoronary Artery Disease, 1992
- Antiperoxidative Actions of Calcium Antagonists and AtherogenesisJournal of Cardiovascular Pharmacology, 1991
- Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: Results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy)Cardiovascular Drugs and Therapy, 1990
- A Review of Calcium Antagonists and AtherosclerosisJournal of Cardiovascular Pharmacology, 1990
- Lipid peroxidation of phosphatidylcholine liposomes depressed by the calcium channel blockers nifedipine and verapamil and by the antiarrhythmic-antihypoxic drug stobadineBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Effect of small molecules on the dipalmitoyl lecithin liposomal bilayer: III. Phase transition in lipid bilayerThe Journal of Membrane Biology, 1977
- Diffusion of univalent ions across the lamellae of swollen phospholipidsJournal of Molecular Biology, 1965
- X-ray Diffraction Pattern of Nerve Myelin: A Method for Determining the PhasesScience, 1963